BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative Employers
  Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

Powered by Business Wire
Biotechnology Headlines

Fuse Medical, Inc. Signs Non-Binding Letter of Intent to Purchase all of the Outstanding Membership Units of CPM Medical Consultants, LLC

RICHARDSON, Texas--(BUSINESS WIRE)--Fuse Medical, Inc. (OTCQX: FZMD) (“Fuse” or the “Company”) announced today that it signed a non-binding Letter of Intent (“LOI”) to purchase all of the outstanding membership units of CPM Medical Consultants, LLC (“CPM”), a privately-owned national distributor of medical device implants and biologics.

“We are thrilled with the prospects a combined Fuse and CPM strategic growth platform would offer”

CPM is a stocking distributor with a broad portfolio of orthopedic implants for total joint reconstruction, sports medicine, internal and external fixation products for extremities, and full spinal implants and instrumentation. CPM also offers an extensive product catalog of biologics, which include human allograft with cell based products, regenerative tissue, and amniotic fluids to augment all types of surgical procedures.

CPM is owned and controlled by the Company’s Chairman of the Board of Directors, Mark W. Brooks, and is the Company’s current principal supplier.

Although no binding obligation will be created until the execution of a definitive purchase agreement, the Company and the members of CPM are currently negotiating the definitive purchase agreement with a targeted fourth quarter close date.

Christopher C. Reeg, the Company’s Chief Executive Officer, commented, “The acquisition of CPM would be the initial step for Fuse to take in becoming a viable national entity within this highly competitive space. We are delighted the Fuse Board of Directors approved the non-binding LOI and especially appreciate the hard work and dedication of the independent Special Committee of the Board of Directors to date.”

“We are thrilled with the prospects a combined Fuse and CPM strategic growth platform would offer,” Mr. Brooks added.

About Fuse Medical, Inc.

Fuse provides a broad portfolio of orthopedic implants including internal and external fixation products, upper and lower extremity plating and total joint reconstruction, soft tissue fixation and augmentation for sports medicine procedures, full spinal implants for trauma, degenerative disc disease and deformity indications, and human allografts, substitute bone materials and tendons, as well as regenerative tissues and fluids to support orthopedic surgeries and wound care. For more information about Fuse, please visit: www.fusemedical.com.

Forward-Looking Statements

Certain statements in this press release, including those related to an anticipated purchase of all of the outstanding membership units and plans for the combined company, constitute “forward-looking statements” within the meaning of the federal securities laws. Words such as “may,” “might,” “will,” “should,” “believe,” “expect,” “anticipate,” “estimate,” “continue,” “predict,” “forecast,” “project,” “plan,” “intend” or similar expressions, or statements regarding intent, belief, or current expectations, are forward-looking statements. While the Company believes these forward-looking statements are reasonable, undue reliance should not be placed on any such forward-looking statements, which are based on information available to us on the date of this release. These forward-looking statements are based upon current estimates and assumptions and are subject to various risks and uncertainties, including without limitation those set forth in the Company’s filings with the Securities and Exchange Commission, failure of the company to execute a definitive Purchase agreement and close the transaction, and integration issues with the combined company. Thus, actual results could be materially different. The Company expressly disclaims any obligation to update or alter statements whether as a result of new information, future events or otherwise, except as required by law.

Contacts

Fuse Medical, Inc.
Devon Peddie, 469-862-3030
Facsimile 469-862-3035
info@Fusemedical.com